216 related articles for article (PubMed ID: 19436992)
1. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
Kawashima Y; Chen J; Sun H; Lann D; Hajjar RJ; Yakar S; Leroith D
Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
[TBL] [Abstract][Full Text] [Related]
2. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.
Zhao H; Yakar S; Gavrilova O; Sun H; Zhang Y; Kim H; Setser J; Jou W; LeRoith D
Diabetes; 2004 Nov; 53(11):2901-9. PubMed ID: 15504971
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
Li J; Wang Q; Chai W; Chen MH; Liu Z; Shi W
Cardiovasc Diabetol; 2011 Dec; 10():117. PubMed ID: 22204493
[TBL] [Abstract][Full Text] [Related]
4. MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity.
Vaitheesvaran B; LeRoith D; Kurland IJ
Diabetologia; 2010 Oct; 53(10):2224-32. PubMed ID: 20577711
[TBL] [Abstract][Full Text] [Related]
5. Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice.
Hofmann SM; Perez-Tilve D; Greer TM; Coburn BA; Grant E; Basford JE; Tschöp MH; Hui DY
Diabetes; 2008 Jan; 57(1):5-12. PubMed ID: 17914034
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
[TBL] [Abstract][Full Text] [Related]
7. TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice.
Di Bartolo BA; Chan J; Bennett MR; Cartland S; Bao S; Tuch BE; Kavurma MM
Diabetologia; 2011 Dec; 54(12):3157-67. PubMed ID: 21965021
[TBL] [Abstract][Full Text] [Related]
8. Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.
Mosa R; Huang L; Wu Y; Fung C; Mallawakankanamalage O; LeRoith D; Chen C
Endocrinology; 2017 Oct; 158(10):3174-3187. PubMed ID: 28977588
[TBL] [Abstract][Full Text] [Related]
9. Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice.
Kim H; Pennisi PA; Gavrilova O; Pack S; Jou W; Setser-Portas J; East-Palmer J; Tang Y; Manganiello VC; Leroith D
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1227-36. PubMed ID: 16682489
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.
Kim H; Haluzik M; Gavrilova O; Yakar S; Portas J; Sun H; Pajvani UB; Scherer PE; LeRoith D
Diabetologia; 2004 Dec; 47(12):2215-25. PubMed ID: 15662559
[TBL] [Abstract][Full Text] [Related]
12. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
Boord JB; Maeda K; Makowski L; Babaev VR; Fazio S; Linton MF; Hotamisligil GS
Circulation; 2004 Sep; 110(11):1492-8. PubMed ID: 15353487
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE
Han JH; Oh TJ; Lee G; Maeng HJ; Lee DH; Kim KM; Choi SH; Jang HC; Lee HS; Park KS; Kim YB; Lim S
Diabetologia; 2017 Feb; 60(2):364-376. PubMed ID: 27866224
[TBL] [Abstract][Full Text] [Related]
15. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
Fujii A; Allen TJ; Nestel PJ
Atherosclerosis; 2007 Jul; 193(1):55-61. PubMed ID: 16996521
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes.
List EO; Palmer AJ; Berryman DE; Bower B; Kelder B; Kopchick JJ
Diabetologia; 2009 Aug; 52(8):1647-55. PubMed ID: 19468705
[TBL] [Abstract][Full Text] [Related]
17. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance.
Gao J; Katagiri H; Ishigaki Y; Yamada T; Ogihara T; Imai J; Uno K; Hasegawa Y; Kanzaki M; Yamamoto TT; Ishibashi S; Oka Y
Diabetes; 2007 Jan; 56(1):24-33. PubMed ID: 17192461
[TBL] [Abstract][Full Text] [Related]
18. Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.
Johanson EH; Jansson PA; Lönn L; Matsuzawa Y; Funahashi T; Taskinen MR; Smith U; Axelsen M
J Clin Endocrinol Metab; 2003 Sep; 88(9):4232-8. PubMed ID: 12970292
[TBL] [Abstract][Full Text] [Related]
19. Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.
Huang ZH; Reardon CA; Getz GS; Maeda N; Mazzone T
J Lipid Res; 2015 Feb; 56(2):215-26. PubMed ID: 25421060
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
